Hemostasis and fibrinolysis activation after subarachnoid hemorrhage

Journal of Neurosurgery

Volumn 87, Issue 2, 1997, Pages 207-214

  Peltonen, Seija ^a   Juvela, Seppo ^a   Kaste, Markku ^a   Lassila, Riitta ^a,b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b WIHURI RESEARCH INSTITUTE   (Finland)

Author keywords

D dimer; Fibrinolysis; Hemostasis; Plasminogen activator inhibitor 1; Subarachnoid hemorrhage; Thrombin antithrombin III complex

Indexed keywords

ANTITHROMBIN III; D DIMER; FIBRIN DEGRADATION PRODUCT; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; THROMBIN;

ADULT; ANEURYSM SURGERY; ARTICLE; BRAIN ARTERY ANEURYSM RUPTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; INTRACRANIAL ANEURYSM; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE;

EID: 0030798176     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1997.87.2.0207     Document Type: Article

References (28)

1. Ameriso SF, Wong VLY, Ishii H, et al: Hematogenous factors and prediction of delayed ischemic deficit after subarachnoid hemorrhage. Stroke 23:1404-1409, 1992
2. Amiral J, Grosley M, Mimilla F, et al: Monoclonal antibodies to different neo-epitopes on fibrinogen and fibrin degradation products. Blood Coagul Fibrinolysis 1:447-452, 1990
3. Bauer KA: New markers for in vivo coagulation. Curr Opin Hematol 1:341-346, 1994
4. Boneu B, Bes G, Pelzer H, et al: D-dimers, thrombin antithrombin III complexes and prothrombin fragments 1 + 2: diagnostic value in clinically suspected deep vein thrombosis. Thromb Haemost 65:28-32, 1991
5. Bounameaux H, Cirafici P, de Moerloose P, et al: Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism. Lancet 337:196-200, 1990
6. Broderick JP, Brott T, Tomsick T, et al: Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg 78:188-191, 1993
7. Celi A, Pellegrini G, Lorenzet R, et al: P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA 91:8767-8771, 1994
8. Declerck PJ, Mombaerts P, Holvoet P, et al: Fibrinolytic response and fibrin fragment D-dimer levels in patients with deep vein thrombosis. Thromb Haemost 58:1024-1029, 1987
9. Diquélou A, Lemozy S, Dupouy D, et al: Effect of blood flow on thrombin generation is dependent on the nature of the thrombogenic surface. Blood 84:2206-2213, 1994
10. Drake CG: Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg 68:985-986, 1988 (Letter)
11. Fogelholm R, Hernesniemi J, Vapalahti M: Impact of early surgery on outcome after aneurysmal subarachnoid hemorrhage. A population-based study. Stroke 24:1649-1654, 1993
12. Fujii Y, Takeuchi S, Sasaki O, et al: Hemostasis in spontaneous subarachnoid hemorrhage. Neurosurgery 37:226-234, 1995
13. Fujii Y, Tanaka R, Takeuchi S, et al: Serial changes in hemostasis after intracranial surgery. Neurosurgery 35:26-33, 1994
14. Gerschlick AH: Are there markers of the blood-vessel wall interaction and of thrombus formation that can be used clinically? Circulation 81 (Suppl 1):I28-I34, 1990
15. 2-plasmin inhibitor complex in the acute stage of nontraumatic subarachnoid hemorrhage. Neurosurgery 35:1055-1060, 1994
16. Jackson CM: Mechanisms of prothrombin activation, in Colman RW Hirsh J, Marder VJ, et al (eds): Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia: JB Lippincott, 1987, pp 135-147
17. Jennett B, Bond M: Assessment of outcome after severe brain damage. A practical scale. Lancet 1:480-484, 1975
18. Juvela S: Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurosurg 82:945-952, 1995
19. Kassis J, Hirsh J, Podor TJ: Evidence that postoperative fibrinolytic shutdown is mediated by plasma factors that stimulate endothelial cell type I plasminogen activator inhibitor biosynthesis. Blood 80:1758-1764, 1992
20. Kay R, Wong KS, Yu YL, et al: Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 333:1588-1593, 1995
21. Kishimoto T: The biology of interleukin-6. Blood 74:1-10, 1978
22. Kluft C, Verheijen JH: Leiden Fibrinolysis Working Party: blood collection and handling procedures for assessment of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1). Fibrinolysis 4 (Suppl 2):155-161, 1990
23. Lassila R, Peltonen S, Lepäntalo M, et al: Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin. Arterioscler Thromb 13:1738-1742, 1993
24. Peltonen S, Lassila R, Rossi P, et al: Blood coagulation and fibrinolysis activation during sudden arterial occlusion of lower extremities - an association with ischemia and patient outcome. Thromb Haemost 74:1442-1446, 1995
25. Schneiderman J, Bordin GM, Engelberg I, et al: Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. A possible mechanism for aneurysm expansion. J Clin Invest 96:639-645, 1995
26. Siljander P, Carpen O, Lassila R: Platelet-derived microparticles associate with fibrin during thrombosis. Blood 87:4651-4663, 1996
27. Simon DI, Ezratty AM, Loscalzo J: The fibrin(ogen)olytic properties of cathepsin D. Biochemistry 33:6555-6563, 1994
28. Takano K, Yamaguchi T, Uchida K: Markers of hypercoagulable state following acute ischemic stroke. Stroke 23:194-198, 1992